Anti-KMT1E / SETDB1 antibody
2
(4 리뷰들)
|
(32 제품이 사용된 논문 )
Rabbit Polyclonal KMT1E / SETDB1 antibody. Suitable for WB and reacts with Human samples. Cited in 32 publications. Immunogen corresponding to Synthetic Peptide within Human SETDB1 aa 1100 to C-terminus.
대체 명칭 보기
ESET, KIAA0067, KMT1E, SETDB1, Histone-lysine N-methyltransferase SETDB1, ERG-associated protein with SET domain, Histone H3-K9 methyltransferase 4, Lysine N-methyltransferase 1E, SET domain bifurcated 1, H3-K9-HMTase 4
- WB
CiteAb
Western blot - Anti-KMT1E / SETDB1 antibody (AB12317)
Western Blotting using Anti-KMT1E / SETDB1 antibody, ab12317. Publication image from Li, J. et al., 2015, Nucleic Acids Res, 26405197. Legend direct from paper.
Ribosomes have a SetDB1-dependent H3K9 methyltransferase activity. (A) Increasing amounts of ribosomes (0.2 and 0.6 ug of RNA) were analyzed by Western blot, as indicated. (B) Western blot analysis of samples derived from immunoprecipitation assays using 50 ug of ribosomal RNA with antibodies against SetDB1 and RPS3a, as well as rabbit antibodies, as negative control. (C) Western blot of HeLa cell extracts treated with 30 nM of either control or SetDB1 siRNA for 72 h, blotted as indicated. (D) Western blot of ribosomes purified by sucrose gradient from HeLa cells treated with 30 nM of either control or SetDB1 siRNA for 72 h, blotted as indicated. 50 ug of S100 cytosolic extract was loaded as a positive control. (E) Histone methyltransferase assay using 3H-SAM, 5 µM of histone H3 peptides from amino acids 1–20 that were either unmodified or trimethylated at the lysine 9, and ribosomes purified by sucrose gradient from HeLa cells treated with 30 nM of either control or SetDB1 siRNA for 72 h. H3K9 methylation value was obtained subtracting the cpms obtained in the reaction using H3(1–20)K9me3 peptide from the cpms obtained in the reaction containing the H3(1–20) peptide. Standard deviation was obtained from triplicates.
false
- WB
CiteAb
Western blot - Anti-KMT1E / SETDB1 antibody (AB12317)
Western Blotting using Anti-KMT1E / SETDB1 antibody, ab12317. Publication image from Li, J. et al., 2015, Nucleic Acids Res, 26405197. Legend direct from paper.
Ribosomes have a SetDB1-dependent H3K9 methyltransferase activity. (A) Increasing amounts of ribosomes (0.2 and 0.6 ug of RNA) were analyzed by Western blot, as indicated. (B) Western blot analysis of samples derived from immunoprecipitation assays using 50 ug of ribosomal RNA with antibodies against SetDB1 and RPS3a, as well as rabbit antibodies, as negative control. (C) Western blot of HeLa cell extracts treated with 30 nM of either control or SetDB1 siRNA for 72 h, blotted as indicated. (D) Western blot of ribosomes purified by sucrose gradient from HeLa cells treated with 30 nM of either control or SetDB1 siRNA for 72 h, blotted as indicated. 50 ug of S100 cytosolic extract was loaded as a positive control. (E) Histone methyltransferase assay using 3H-SAM, 5 µM of histone H3 peptides from amino acids 1–20 that were either unmodified or trimethylated at the lysine 9, and ribosomes purified by sucrose gradient from HeLa cells treated with 30 nM of either control or SetDB1 siRNA for 72 h. H3K9 methylation value was obtained subtracting the cpms obtained in the reaction using H3(1–20)K9me3 peptide from the cpms obtained in the reaction containing the H3(1–20) peptide. Standard deviation was obtained from triplicates.
false
Reactivity 정보
특성 및 보관 정보
제형
Purification 테크닉
Purification 관련 사항
보관 버퍼
배송 시 보관 조건
적절한 단기 보관 기간
적절한 단기 보관 조건
적절한 장기 보관 조건
분주 정보
보관 정보
추가 정보
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The methyltransferase SETDB1 impacts chromatin structure and gene silencing. It operates as a part of the histone methylation complex collaborating with co-factors like ATF7IP and MBD1 to achieve highly specific gene repression. By catalyzing trimethylation of H3K9 it creates a binding site for HP1 proteins facilitating the formation of heterochromatin. This action is essential for processes such as X-chromosome inactivation and the repression of transposable elements.
Pathways
Regulation through SETDB1 influences key biological processes. This enzyme is integral to the PRC2 (Polycomb Repressive Complex 2) pathway maintaining transcriptional silencing during development. Furthermore SETDB1 works alongside SUV39H1 in dynamic change of heterochromatin states regulating genes involved in cell cycle and differentiation. Such pathways highlight its significant interactions with proteins like EZH2 and EED which assist in maintaining stable gene silencing.
제품 프로토콜
- Visit the General protocols
- Visit the Troubleshooting
타겟 정보
제품이 사용된 논문 (32)
Recent publications for all applications. Explore the 전체 목록 and refine your search
Frontiers in cellular and infection microbiology 15:1537929 PubMed40270769
2025
Applications
Unspecified application
Species
Unspecified reactive species
Epigenetics & chromatin 18:2 PubMed39800758
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 42:113414 PubMed37967011
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of immunology research 2022:4012920 PubMed35497876
2022
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cell 82:816-832.e12 PubMed35081363
2022
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of experimental medicine 219: PubMed34825915
2021
Applications
Unspecified application
Species
Unspecified reactive species
ACS chemical biology 16:1721-1736 PubMed34415726
2021
Applications
Unspecified application
Species
Unspecified reactive species
PLoS pathogens 16:e1008834 PubMed32956422
2020
Applications
Unspecified application
Species
Unspecified reactive species
Journal of virology 94: PubMed32493816
2020
Applications
Unspecified application
Species
Unspecified reactive species
Cell 181:800-817.e22 PubMed32302590
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com